140 related articles for article (PubMed ID: 26275496)
1. [Evaluation of the knowledge of patients about the management of treatment with anti-vitamin K drugs in the Service of Cardiology of Ouagadougou].
Samadoulougou AK; Naibe DT; Mandi DG; Kabore E; Millogo GR; Yameogo NV; Kologo JK; Tall AT; Toguyeni BJ; Zabsonre P
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):263-7. PubMed ID: 26275496
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in children participating in a non-selective INR self-monitoring VKA-education programme.
Amedro P; Bajolle F; Bertet H; Cheurfi R; Lasne D; Nogue E; Auquier P; Picot MC; Bonnet D
Arch Cardiovasc Dis; 2018 Mar; 111(3):180-188. PubMed ID: 29100908
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic education of elderly patients under antivitamin - K treatment: evaluation of the program after 5 years].
Thiriat N; Peyron I; Bernard-Charrière S; Monti A; Pariel S; Pautas E
J Pharm Belg; 2014 Sep; (3):30-7. PubMed ID: 25226761
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulant treatment - evaluating the knowledge of patients admitted in physical medicine and rehabilitation units.
Janoly-Duménil A; Bourne C; Loiseau K; Luauté J; Sancho PO; Ciancia S; Caillet F; Boisson D; Rioufol C; Plauchu MM; Rode G; Jacquin-Courtois S
Ann Phys Rehabil Med; 2011 May; 54(3):172-80. PubMed ID: 21474406
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the level of knowledge of patients on treatment with vitamin K antagonists in Ouagadougou cardiology department].
Samadoulougou A; Temoua Naibe D; Mandi G; Yameogo RA; Kabore E; Millogo G; Yameogo NV; Kologo JK; Thiam Tall A; Toguyeni BJ; Zabsonre P
Pan Afr Med J; 2014; 19():286. PubMed ID: 25870741
[TBL] [Abstract][Full Text] [Related]
8. [Accidents in patients under anticoagulant therapy in the Department of Cardiology at the Yalgado Ouedraogo Teaching Hospital, Ouagadougou (Burkina Faso)].
Millogo GRC; Kologo JK; Kinda G; Yaméogo NV; Tougma JB; Kambiré Y; Thiam AT; Sanon B; Toguyeni JY; Samadoulougou A; Zabsonré P
Pan Afr Med J; 2018; 29():135. PubMed ID: 30050599
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
10. [Follow-up of patients treated by VKA: Interest of a pharmaceutical link between the hospital and the retail pharmacies].
Bidon D; Lecoeur A; Segui E; Seguette N; Le Mercier F; Bauler S
Ann Pharm Fr; 2017 Jan; 75(1):45-53. PubMed ID: 27234455
[TBL] [Abstract][Full Text] [Related]
11. [A long-term follow-up quality evaluation of patients taking oral anticoagulant therapy].
Chastagner M; Gault M; Aboyans V; Lacroix P
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):199-204. PubMed ID: 15816322
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin K antagonist overdose induced blindness in an infant: an argument for a therapeutic educational program].
Bui Quoc E; Bonnet D; Bajolle F
Arch Pediatr; 2012 Jan; 19(1):22-6. PubMed ID: 22169573
[TBL] [Abstract][Full Text] [Related]
13. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
15. Approaches to optimal dosing of vitamin K antagonists.
Witt DM
Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of anticoagulation with vitamin K antagonists in acute stroke patients with atrial fibrillation--Hungarian results].
Sas A; Csontos K; Lovász R; Valikovics A
Ideggyogy Sz; 2015 Jan; 68(1-2):47-51. PubMed ID: 25842916
[TBL] [Abstract][Full Text] [Related]
17. [Educational and information needs of patients under vitamin K antagonist therapy].
Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of the quality of oral anticoagulation management in patients admitted to Amiens University Hospital].
Gras-Champel V; Voyer A; Lematte C; Pakula P; Roussel B; Lefrère JJ; Andréjak M
Therapie; 2005; 60(2):149-57. PubMed ID: 15969317
[TBL] [Abstract][Full Text] [Related]
19. [Overdose in Vitamin K antagonists administration in Dakar: epidemiological, clinical and evolutionary aspects].
Dia K; Sarr SA; Mboup MC; Ba DM; Fall PD
Pan Afr Med J; 2016; 24():186. PubMed ID: 27795783
[TBL] [Abstract][Full Text] [Related]
20. [What is the current use of vitamin K antagonists in the elderly?].
Vidal JS; Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
